Accolade Market Cap

ReproCELL has a market cap or net worth of 20.07 billion as of August 1, 2025. Its market cap has increased by 62.36% in one year.

Market Cap

20.07B

Enterprise Value

16.13B

Revenue

2.98B

Ranking

n/a

PE Ratio

191.11

Stock Price

$212.00

Market Cap Chart

Since June 27, 2013, ReproCELL's market cap has decreased from 145.35B to 20.07B, a decrease of -86.19%. That is a compound annual growth rate of -15.09%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	20.07B	104.84%
Dec 30, 2024	9.80B	-34.19%
Dec 29, 2023	14.89B	-42.13%
Dec 30, 2022	25.73B	35.26%
Dec 30, 2021	19.02B	-35.21%
Dec 30, 2020	29.36B	94.87%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	12.19T
Daiichi Sankyo Company	6,928.82B
Takeda Pharmaceutical Company	6,560.37B
HOYA Corporation	6,488.42B
Otsuka Holdings	3,820.98B
Terumo	3,777.35B
Astellas Pharma	2,663.98B
Shionogi &	2,151.21B

Market Cap Rankings